Ovation formulation may soon be available in over 2800 clinics

Vancouver, British Columbia When Las Vegas, September 7, 2022 /PRNewswire/ – (CSE: OVAT) (OTCQB: OVATF) – Ovation Science Inc. (“Ovation” or the “Company”) is a developer of topical and transdermal cannabis products with its patented dermal delivery technology, Invisicare®. Yes, and we are happy to announce it.It signed an exclusive licensing deal for state cannabis preparations Oklahoma, Missouri, new mexico When Mississippi Stash House Distribution (“Stash House”). Stash House is one of the nation’s leading cannabis manufacturing, marketing and distribution companies. Ovation receives royalties based on wholesale sales in each state. With this agreement, Ovation solidifies its marketing strategy, increases revenue by licensing into new states, and revitalizes growth momentum across North America.

“Launching a topical product with Stash House, which has an experienced product marketing and distribution team in four states, is an important step for us.” Terry Howlett, CEO of Ovation Science. “This expansion will establish our products in markets that really need our science-based products. We are an experienced manufacturer and distributor with a robust technology platform. That’s why we partnered with Stash House, who have both the knowledge and expertise to ensure our products resonate with pharmacies and customers.”

“We would like to incorporate Ovation formulations into our portfolio,” he said. Shane Finn, COO of Stash House. “We are fascinated by the science behind Ovation’s technology and know that consumers will soon reap the benefits of these products. Oklahomaand now on sale Missourifollowed by new mexicoWhen Mississippi in the fourth quarter. We plan to rapidly expand across these states by introducing Ovation formulations under our brand and targeting leading pharmacies with superior products with proven technology. I’m here. So we are very excited about this opportunity and working with Ovation Science. “

Ovation’s expansion represents a significant increase in the availability of Ovation products through licensees from its current 92 pharmacies. Nevada Five states may have over 2,800 pharmacies (estimated total number of licensed pharmacies).

Ovation leverages its expertise in the pharmaceutical industry to develop unique, highly effective products. What sets Ovation’s products apart from other topical cannabis products on the market is his superior delivery of CBD/THC and other cannabinoids using a proprietary dermal delivery technology, Invisicare®. Invisicare has over 20 years of research and development experience in the pharmaceutical industry. Specifically dermatology. Ovation he prescribes two topical medications. What remains on the skin to address “skin problems” and transdermal creams that allow CBD (cannabidiol) and/or THC (tetrahydrocannabinol) and other cannabinoids to be absorbed through the skin and into the bloodstream. Ovation’s products have been shown to deliver 10x more CBD into the skin and more than 5x more penetration than other products tested.

Statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent disease.

About stash house distribution

Stash House Distribution (www.stashhousedistro.com) manufactures and distributes a wide variety of finished cannabis products to meet the needs of pharmacy customers.of Oklahoma, Stash House cemented its strength in the market by partnering with some of the most well-known domestic brands. The company’s proprietary technology platform enables his stress-free 24-hour dispensing orders and brand transparency at the customer’s fingertips. This technology platform, combined with solid experience in distribution and sales, separates Stash House from other markets.

About Ovation Science

Ovation Science Inc. is a research and development company that develops topical and transdermal consumer products, including CBD/THC and other cannabinoid formulations. These products are licensed and marketed under Ovation’s own brand. ARLO CBD Beauty and InVibe® MD (“Health & Wellness” line); all made with patented Invisicare® skin delivery technology. Invisicare technology enhances the delivery of ingredients to and through the skin and is protected by non-reproducible patents and proprietary formulations. With over 20 years of experience in topical and transdermal drug delivery in the pharmaceutical market, Ovation’s management and scientific team has built a unique pipeline of over 30 unique medical/wellness topical and transdermal products into a series of Created with our anti-aging/beauty formula. Ovation derives its income from a licensee’s sales and royalties on his Invisicare sales, as well as sales of its own products. Ovation has an office. Vancouver, British Columbia Canada When Las Vegas, Nevada,usa.
Ovation is trading on the CSE under the symbol OVAT and united states of america On the OTC market under the symbol OVATFFor more information, please visit our website www.ovationscience.com. Product Line: Health and Wellness: www.invibemd.com beauty: www.arlocbdbeauty.com

Forward-Looking Statements

The information contained in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management’s current estimates, beliefs, intentions and expectations, many of which could cause actual results to differ materially from those set forth in the forward-looking statements. subject to the risks and uncertainties of In particular, there is no guarantee of sale and acceptance of the product in any of his four states cited. Nevada or expanding distribution to other states, or continued sales in pharmacy or retail markets. It is not a guarantee of future performance or regulatory changes. Ovation Science Inc. assumes that all forward-looking statements are inherently uncertain and that actual results may be affected by a number of important factors, many of which are within the control of Ovation Science Inc. I warn you not to. Accordingly, readers should not place undue reliance on forward-looking information. Ovation disclaims any obligation to revise or update such forward-looking information to reflect future results, events or circumstances, except as required by law.

Neither the Canadian Stock Exchange, OTC Markets nor their regulated service providers are responsible for the adequacy or accuracy of this release.

SOURCE Ovation Science Inc.